Literature DB >> 30943787

Accuracy of a Point-of-Care Hemoglobin A1c Assay.

David M Nathan1,2, Amanda Griffin1, Francesca M Perez3, Erica Basque4, Lily Do1, Barbara Steiner1.   

Abstract

Point-of-care test (POCT) HbA1c assays provide rapidly available results for clinical decision-making. Accuracy and precision must be established. Venous blood samples from 300 patients were assayed for HbA1c by a laboratory technician ("laboratory assessment") with the POCT Alere Afinion™ assay and a laboratory (Premier AffinityTM) assay. POCT results from 402 patients' fingerstick samples assayed by nine nontechnician staff ("clinical assessment") were compared with the laboratory assay. The laboratory assessment showed tight correlation (r2 = .977, P < .001) between the assays. Mean absolute and relative differences were 0.01 percentage points and 2.1%, respectively. CVs for the POCT and laboratory assays were <2% and <1%, respectively. The clinical assessment also showed a tight correlation between the assays (r2 = .978, P < .001), with mean absolute and relative differences of 0.2 percentage points and 3.41%, respectively. CV for the POCT assay was <2%. The POCT performed acceptably compared to the laboratory assay under realistic clinical conditions.

Entities:  

Keywords:  HbA1c; glycohemoglobin; point of care

Year:  2019        PMID: 30943787      PMCID: PMC6835193          DOI: 10.1177/1932296819836101

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  22 in total

1.  Diagnosing diabetes mellitus: performance of hemoglobin A1c point-of-care instruments in general practice offices.

Authors:  Una Ørvim Sølvik; Thomas Røraas; Nina Gade Christensen; Sverre Sandberg
Journal:  Clin Chem       Date:  2013-08-19       Impact factor: 8.327

2.  Executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Authors:  David B Sacks; Mark Arnold; George L Bakris; David E Bruns; Andrea Rita Horvath; M Sue Kirkman; Ake Lernmark; Boyd E Metzger; David M Nathan
Journal:  Clin Chem       Date:  2011-05-26       Impact factor: 8.327

3.  Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients.

Authors:  E Cagliero; E V Levina; D M Nathan
Journal:  Diabetes Care       Date:  1999-11       Impact factor: 19.112

4.  The clinical information value of the glycosylated hemoglobin assay.

Authors:  D M Nathan; D E Singer; K Hurxthal; J D Goodson
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

5.  Assessment of a glycated hemoglobin point-of-care analyzer (A1CNow+) in comparison with an immunoturbidimetric method: a diagnostic accuracy study.

Authors:  Aurélie Affret; Luiz Henrique Maciel Griz; Eduarda Ângela Pessoa Cesse; Yuri da Silva Specht; Eduardo Maia Freese de Carvalho; Annick Fontbonne
Journal:  Sao Paulo Med J       Date:  2015-04-14       Impact factor: 1.044

6.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

7.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

8.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  Improvement in the Quality of HbA1c Determination by Using Commutable Specimens With IFCC-Assigned Values.

Authors:  Rui Zhou; Zhi-Qi Gao; Qing Tong; Chang Zuo; Zhi-Xin Song; Wei Wang; Qing-Tao Wang
Journal:  Lab Med       Date:  2017-05-01

10.  Point-of-care measurements of HbA(1c): simplicity does not mean laxity with controls.

Authors:  Viviane Leca; Zouher Ibrahim; Elise Lombard-Pontou; Marie Maraninchi; Régis Guieu; Henri Portugal; René Valéro; Bernard Vialettes
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112

View more
  3 in total

1.  Analysis: Investigating the quality of POCT devices for HbA1c, what are our next steps?

Authors:  Erna Lenters-Westra; Emma English
Journal:  J Diabetes Sci Technol       Date:  2019-05-21

2.  Relationship Between Time-in-Range, HbA1c, and the Glucose Management Indicator in Pregnancies Complicated by Type 1 Diabetes.

Authors:  Viral N Shah; Janet K Snell-Bergeon; Jamie K Demmitt; Prakriti Joshee; Rachel Garcetti; Laura Pyle; Sarit Polsky
Journal:  Diabetes Technol Ther       Date:  2021-11-03       Impact factor: 6.118

Review 3.  Current Challenges and Future Trends of Enzymatic Paper-Based Point-of-Care Testing for Diabetes Mellitus Type 2.

Authors:  Margarita Ortiz-Martínez; Raquel Flores-DelaToba; Mirna González-González; Marco Rito-Palomares
Journal:  Biosensors (Basel)       Date:  2021-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.